Stockreport

Did Phase 3 Completion and 2025 Losses Just Shift Pharvaris' (PHVS) Investment Narrative? [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF Alongside these results, the company highlighted progress in its hereditary angioedema pipeline, including completed Phase 3 enrollment and confirmed plans to file a Ne [Read more]